Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Local anaesthesia is a minimal loss of feeling in a specific body part or localized areas. They are administered for treating painful situations, eliminating of pain at the time of major or minor surgeries or also for minimization of post-operative surgery. Some medications are used as local anaesthetic at higher amounts. A local anaesthetic applied to spot directly or absorbed through the skin. Local anaesthesia allows a person to be awake or sedated, depending on the situation. Local anaesthesia have short duration and it is used frequently used for small outpatient procedures. The application of anaesthesia is depending on many factors like duration of action and application of surgery, health of patients and preferences of surgeon and the patients.
The Europe local anaesthetic drug market is witnessing tremendous growth during forecast period of 2021-2027. The need for minimization of pain and patient safety expectation is gaining attention of Europe local anaesthetic drug market. The major dynamic factors like surge in cases to perform surgeries is propelling growth of Europe local anaesthetic drug market. Improvement in drug delivery systems is also refuelling growth of Europe local anaesthetic drug market. Introduction of new and effective drugs is also boosting growth of Europe local anaesthetic drug market. However, side effects associated with the drugs is hampering the growth of Europe local anaesthetic drug market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the local anaesthetic drug market. In addition, complete analysis of changes on local anaesthetic drug expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Europe economies, international trade, business investments, GDP and marketing strategies of key players present in the market. There is slight slow growth of local anaesthetic drug market is experienced during the COVID-19 situation as there is several restraining factors like mismatch between demand and supply due to complete shutdown in many countries which hampered the transportation of general anaesthetic drugs. The several surgical procedures are post ponded during the time of COVID-19 pandemic. However, activities are resuming and all the pending surgeries are being held nowadays. The market acquired its original state and witnessing rapid growth during the forecast period 2021-2027.
The Europe local anaesthetic drug market is categorised by drug molecules, route of administration, distribution channel and country.
The Europe local anaesthetic drug molecules is comprised of bupivacaine, lidocaine, benzocaine, ropivacaine, prilocaine, Chloroprocaine and other local anaesthetic drugs. In which benzocaine is also contributing in the growth of Europe local anaesthetic drug market. The benzocaine is used as pain reliver from minor mouth problems like toothache, canker sores, sore gums or throat, mouth or gum injury. It is marketed in some over the counter oral product. It has some side effects like bluish colored lips, fingernails or palms, difficulty in breathing, dizziness or light headedness and rapid heart rate. They are mostly used in the products which are used for oral ulcer.
The Europe local anaesthetic drug market is comprised of route of administrations like intravenous local anaesthesia, topical local anaesthesia and ophthalmic local anaesthesia. In which ophthalmic local anaesthesia is also contributing in the growth of Europe local anaesthetic drug market. The ophthalmic local anaesthetic is an integral part of ophthalmology since decades. Most commonly used drugs like proparacaine, tetracaine, benoxinate and lidocaine. They are generally tolerated by body is prescribed doses but can cause toxic effects if abused.
The Europe local anaesthetic drug market is comprised of distribution channels like online pharmacies, retail pharmacies and hospital pharmacies. In which online pharmacies are also contributing in the growth of Europe local anaesthetic drug market. The online pharmacies supplies medicines directly at the door step of patients. The online pharmacies are preferred during the COVID-19 pandemic as there is complete shutdown over 140 countries and need for maintaining social distancing among the peoples. The online pharmacies also provides special offers and discounts over the various medicine which is also gaining market attention of Europe local anaesthetic drug market.
The Europe local anaesthetic drug market is studied for countries like UK, France, Italy, Germany and Spain. In which United Kingdom is anticipated to dominate the market in 2020. The rising government initiatives for patient safety during surgical procedure is propelling the growth of Europe local anaesthetic drug market. The rising technological advancement in drug deliveries is also refuelling growth of Europe local anaesthetic drug market. Rising launch of new anaesthetic drug is also elevating growth of Europe local anaesthetic drug market.
The key players operating in the local anaesthetic drug market are Advanced Pharma Inc., Akorn Inc., Aspen Pharmacare, Baxter International Inc., Fresenius Kabi, Glenmark Pharmaceuticals Inc., Mylan, Novartis Ag, Pacira Pharmaceutical, Pfizer Inc., Sagent Pharmaceutical and Teva Pharmaceutical Industries Ltd. among the others.
November 2018: Septodont announced launch of Dentapen which is an electronic syringe for use of dental anaesthesia.
April 2018: B. Braun Medical Inc. introduced their first FDA- granted local anaesthetic for use in spinal anaesthesia named Clorotekal® which composed of Chloroprocaine hydrochloride.
• Astrazeneca offers various anaesthetic products in their portfolio like Carbocaine (mepivacaine). Citanest (prilocaine), Dipitan (propofol), EMLA (lidocaine + prilocaine), Marcaine (bupivacaine), Naproin (ropivacaine) and Xylocaine (lidocaine/ lignocaine).
• Glenmark Pharmaceutical offered lidocaine ointment name Fougera for topical anaesthetic purpose comprised of lidocaine ointment USP, 5%.
The study comprised of local anaesthetic drug market. In which different segment of market are analysed. The market segments like drug molecules, route of administrations and distribution channels are analysed in the study. The study also imparts the dominating segments of the market. The drug molecules segment is dominated by lidocaine. Likewise, route of administration segment is dominated by intravenous route and distribution channel is dominated by hospital pharmacies. The study also imparts the geographical section of the market and it analysed that United Kingdom is dominating the market in 2020. The study also imparts impact of COVID-19 on local anaesthetic drug market and it concludes that there is slight slow growth of local anaesthetic drug market is experienced during the COVID-19 situation as there is several restraining factors like mismatch between demand and supply due to complete shutdown in many countries which hampered the transportation of general anaesthetic drugs. The several surgical procedures are post ponded during the time of COVID-19 pandemic. However, activities are resuming and all the pending surgeries are being held nowadays. The market acquired its original state and witnessing rapid growth during the forecast period 2021-2027. The study also analysed various key players operating in the market.
Why to buy this report
